Fludarabine 50mg injections fludarabine phosphate
50mg powder or solution for injection for i.
Its Bioniche Pharma unit was given FDA approval of its ANDA for fludarabine phosphate
injection USR 25 mg/mL, packaged in 50 mg/2 mL single-dose vials.
M2 EQUITYBITES-October 5, 2010-Mylan Inc awarded approval for Fludarabine Phosphate
Injection, USP(C)2010 M2 COMMUNICATIONS http://www.
M2 PHARMA-October 4, 2010-Mylan gains FDA nod for Fludarabine Phosphate
Injection, USP(C)2010 M2 COMMUNICATIONS
Subsequently, the patient was started on fludarabine phosphate
single-agent therapy and continued for 6 cycles to completion.
The FDA has granted approval of its ANDA for fludarabine phosphate
injection, 25 mg/ml.
We describe a patient with B-CLL whose B cells expressed CD8, a predominantly T-cell marker also expressed in natural killer cells, and we propose that patients with this uncommon feature of B-CLL might have an increased sensitivity to fludarabine phosphate
, a substance recently often used to treat patients with CLL.
In the fourth quarter of 2007, APP launched liquid and lyophilized Fludarabine Phosphate
as well as four dosage forms of Epirubicin Hydrochloride Injection.
a privately-held oncology and autoimmune disease drug development company, today announced that its New Drug Application (NDA) for fludarabine phosphate
oral tablets (oral fludarabine) was accepted for filing by the U.
a privately-held oncology and autoimmune disease drug development company, today announced that the FDA has granted Orphan Drug Designation to fludarabine phosphate
oral tablets for the treatment of B-cell chronic lymphocytic leukemia.
In October 2007, the Company received tentative approval for Irinotecan Hydrochloride Injection and approvals for Epirubicin Hydrochloride Injection (in four dosage forms), liquid and lyophilized Fludarabine Phosphate
The liquid version of fludarabine, which is the equivalent of fludarabine phosphate
for injection marketed by Teva Parenteral Medicines, Inc.